Sigmund Silber

Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study

Cortes C, Chu M, Schincariol M, Martínez-Hervás Alonso M, Reisbeck B, Zhang R, Murasato Y, Chen S, Lavarra F, Tu S, Silber S, Gutiérrez-Chico J

June 11, 2021 | 10.4244/EIJ-D-20-00598

Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

March 19, 2021 | 10.4244/EIJ-D-19-00866

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Fajadet J, Neumann F, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S

January 20, 2017 | 10.4244/EIJV12I13A262

Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program

Di Mario C, Serruys P, Silber S, Lu S, Wang W, Widimský P, Xu B, Windecker S

November 20, 2016 | 10.4244/EIJV12I10A199

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimský P, Meredith I, Saito S, Richardt G

July 20, 2016 | 10.4244/EIJY15M07_07

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Holmvang L, Richardt G, Eberli F, Stella P, Buszman P, Neumann F, Serruys P, Windecker S, Widimský P, Belardi J, Silber S

October 20, 2015 | 10.4244/EIJY14M07_14

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P

September 22, 2015 | 10.4244/EIJY14M12_13

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention

Vranckx P, Kalesan B, Stefanini G, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys P, Windecker S

June 19, 2015 | 10.4244/EIJV11I2A31

The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment

Stella P, Belkacemi A, Waksman R, Stahnke S, Torguson R, Von Strandmann R, Agostoni P, Sangiorgi G, Silber S

October 28, 2011 | 10.4244/EIJV7I6A113

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial

Silber S, Gutiérrez-Chico J-L, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Naber C, Chevalier B, Serruys P

May 17, 2011 | 10.4244/EIJV7I1A13

Clinical results after coronary stenting with the GenousTM Bio-engineered R stentTM: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry

Silber S, Damman P, Klomp M, Beijk M, Grisold M, Ribeiro E, Suryapranata H, Wójcik J, Sim K, Thijssen J, de Winter R

February 21, 2011

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

Vranckx P, Cutlip D, Mehran R, Kint P-P, Silber S, Windecker S, Serruys P

February 25, 2010

Transferability of data between different drug-eluting stents

Magro M, Onuma Y, Silber S, Serruys P

November 15, 2009 | 10.4244/EIJV5I5A85

Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007

Daemen J, Simoons M, Wijns W, Bagust A, Bos G, Bowen J, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege H, James S, Jüni P, Kastrati A, Kloth S, Kristensen S, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys P, Silber S, Steg P, Tariah I, Wallentin L, Windecker S

January 20, 2009

Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™

Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P

November 20, 2007

'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study

Fort S, Kornowski R, Silber S, Lewis B, Bilodeau L, Almagor Y, van Remortel E, Morice M, Colombo A

August 20, 2007

Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent

Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P

May 22, 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

Sigmund Silber

Latest news